Jan Westerink

5.4k citations

131 papers · 2.7k indexed · h-index 27

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management

Papers in ⓘ

Internal Medicine 12
- Venous Thromboembolism Diagnosis and Management 12
Endocrinology, Diabetes and Metabolism 51
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Diabetes Treatment and Management 20

Co-authors: Frank L.J. Visseren (78 shared papers)Yolanda van der Graaf (33 shared papers)Michiel L. Bots (18 shared papers)Gert J. de Borst (39 shared papers)Eelco J.P. de Koning (3 shared papers)Harold W. de Valk (13 shared papers)Maarten J. Cramer (15 shared papers)L. Jaap Kappelle (23 shared papers)
Journals: Diabetes Care (8 papers)European Heart Journal (8 papers)International Journal of Cardiology (7 papers)Atherosclerosis (6 papers)Cardiovascular Diabetology (5 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Jan Westerink

128 papers receiving 2.7k citations

Peers

Countries citing papers authored by Jan Westerink

Since Specialization

Citations

This map shows the geographic impact of Jan Westerink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Westerink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Westerink more than expected).

Fields of papers citing papers by Jan Westerink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Westerink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Westerink. The network helps show where Jan Westerink may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Westerink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Westerink Line = papers co-authored together Jan Westerink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population Circulation ·Lotte Kaasenbrood, S. Matthijs Boekholdt, Yolanda van der Graaf, Kausik K. Ray, Ron J.G. Peters, John J.P. Kastelein, Pierre Amarenco, John C. LaRosa, Maarten J. Cramer, Jan Westerink, L. Jaap Kappelle, Gert J. de Borst, Frank L.J. Visseren	2016	176
2	Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response European Heart Journal ·Michiel L. Bots, Jan Westerink, Ton J. Rabelink, Eelco J.P. de Koning	2004	175
3	Is the Association Between Flow-Mediated Dilation and Cardiovascular Risk Limited to Low-Risk Populations? Journal of the American College of Cardiology ·Daniel R. Witte, Jan Westerink, Eelco J.P. de Koning, Yolanda van der Graaf, Diederick E. Grobbee, Michiel L. Bots	2005	140
4	Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2 International Journal of Laboratory Hematology ·Robert Beun, Nuray Kuşadasi, Maaike A. Sikma, Jan Westerink, Albert Huisman	2020	120
5	Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes Cardiovascular Diabetology ·Shahnam Sharif, Yolanda van der Graaf, Maarten J. Cramer, L.J. Kapelle, Gert J. de Borst, Frank L.J. Visseren, Jan Westerink, (unknown), Rutger van Petersen, B. G. F. Dinther, Ale Algra, Diederick E. Grobbee, Guy E.H.M. Rutten, L. Jaap Kappelle, Tim Leiner, Hendrik M. Nathoe	2021	114
6	Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis The Journal of Clinical Endocrinology & Metabolism ·Marieke de Vries, Jan Westerink, Karin Kaasjager, Harold W. de Valk	2020	95
7	Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials Cardiovascular Diabetology ·Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L.J. Visseren, Jan Westerink	2017	94
8	Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes Diabetes Care ·Nordin M.J. Hanssen, Jan Westerink, Jean L.J.M. Scheijen, Yolanda van der Graaf, Coen D.A. Stehouwer, Casper G. Schalkwijk, (unknown), Ale Algra, Rick D.E. Grobbee, Guy E.H.M. Rutten, Frank L.J. Visseren, Gert J. de Borst, Jaap Kappelle, Tim Leiner, Hendrik M. Nathoe	2018	80
9	The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study European Heart Journal ·Cilie C van’t Klooster, Paul M. Ridker, Jesper Hjortnaes, Yolanda van der Graaf, Folkert W. Asselbergs, Jan Westerink, Joachim G.J.V. Aerts, Frank L.J. Visseren	2019	63
10	Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2 International Journal of Laboratory Hematology ·Albert Huisman, Robert Beun, Maaike A. Sikma, Jan Westerink, Nuray Kuşadasi	2020	58
11	The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial American Journal of Clinical Nutrition ·Sabine R. Zwakenberg, Pim A. de Jong, Jonas W. Bartstra, Ruth van Asperen, Jan Westerink, Harold de Valk, RHJA Slart, Gert Luurtsema, Jelmer M. Wolterink, Gert J. de Borst, Joost A. van Herwaarden, Marcel A. van de Ree, Leon J. Schurgers, Yvonne T. van der Schouw, Joline W. J. Beulens	2019	57
12	Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases Atherosclerosis ·Daniel Faber, Yolanda van der Graaf, Jan Westerink, Frank L.J. Visseren	2010	51
13	Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population Arteriosclerosis Thrombosis and Vascular Biology ·Eva J.E. Hendriks, Jan Westerink, Pim A. de Jong, Gert J. de Borst, Hendrik M. Nathoe, Willem P.Th.M. Mali, Yolanda van der Graaf, Yvonne T. van der Schouw, Joline W. J. Beulens	2015	44
14	Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis Blood ·Lisette F. van Dam, C.E.A. Dronkers, Gargi Gautam, Åsa Eckerbom, Waleed Ghanima, Jostein Gleditsch, Anders von Heijne, Herman M.A. Hofstee, Marcel M.C. Hovens, Menno V. Huisman, Stan Kolman, Albert T.A. Mairuhu, Mathilde Nijkeuter, Marcel A. van de Ree, Cornelis J. van Rooden, Robin E. Westerbeek, Jan Westerink, Eli Westerlund, Lucia J.M. Kroft, Frederikus A. Klok	2020	40
15	Intimal and medial calcification in relation to cardiovascular risk factors PLoS ONE ·Sabine R. Zwakenberg, Pim A. de Jong, Eva J.E. Hendriks, Jan Westerink, Wilko Spiering, Gert J. de Borst, Maarten J. Cramer, Jonas W. Bartstra, Teddo Doesburg, Femke Rutters, Amber A. van der Heijden, Casper G. Schalkwijk, Leon J. Schurgers, Yvonne T. van der Schouw, Joline W. J. Beulens, (unknown)	2020	39
16	Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy Journal of clinical lipidology ·Charlotte Koopal, A. David Marais, Jan Westerink, Frank L.J. Visseren	2016	38
17	Pharmacological and non-pharmacological interventions to influence adipose tissue function Cardiovascular Diabetology ·Jan Westerink, Frank L.J. Visseren	2011	38
18	The Relation Between HbA1c and Cardiovascular Events in Patients With Type 2 Diabetes With and Without Vascular Disease Diabetes Care ·Guido Kranenburg, Yolanda van der Graaf, Joep van der Leeuw, Hendrik M. Nathoe, Gert J. de Borst, L. Jaap Kappelle, Frank L.J. Visseren, Jan Westerink	2015	38
19	Editor's Choice – Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis European Journal of Vascular and Endovascular Surgery ·Anne Huibers, Jan Westerink, Evelien E. de Vries, Anne Hoskam, Hester M. den Ruijter, Frans L. Moll, Gert J. de Borst	2018	37
20	Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication Journal of the American College of Cardiology ·Anton P. van de Woestijne, Yolanda van der Graaf, Anho Liem, Maarten J. Cramer, Jan Westerink, Frank L.J. Visseren	2013	35

About Jan Westerink

Jan Westerink is a scholar working on Internal Medicine, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Family Practice and Surgery, having authored 131 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Lipoproteins and Cardiovascular Health (24 papers), Diabetes Treatment and Management (20 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers), Cardiovascular Health and Disease Prevention (12 papers), Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Blood Pressure and Hypertension Studies (12 papers). The work is most often cited by research in Internal Medicine (204 citations), Endocrinology, Diabetes and Metabolism (784 citations), Cardiology and Cardiovascular Medicine (966 citations), Surgery (766 citations) and Clinical Biochemistry (100 citations). Jan Westerink has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Frank L.J. Visseren, Yolanda van der Graaf, Michiel L. Bots, Gert J. de Borst, Eelco J.P. de Koning, Harold W. de Valk, Maarten J. Cramer, L. Jaap Kappelle, Ton J. Rabelink and Hendrik M. Nathoe. Their work appears in journals such as Diabetes Care, European Heart Journal, International Journal of Cardiology, Atherosclerosis and Cardiovascular Diabetology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact